News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director m — Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director mRNA Value Chain, Synthesis & ADC, Merck Life Science Services and MD AmpTec GmbH and Tanja Stadie, Head Of Quality, Merck Group/AmpTec GmbH at the official opening of the new mRNA production facility in Hamburg. (from left - Image: Merck KGaA)

10.10.2023 Merck/AmpTec: New mRNA manufacturing site opened in Hamburg

Merck, a leading science and technology company, today became the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services for all critical ...